Pfizer will study the effectiveness of its vaccine against COVID-19 by inoculating the whole population over the age of 12 in a town in southern Brazil, the company said on Wednesday.
The study will be conducted in Toledo, population 143,000, in the west of Parana state, together with Brazil's National Vaccination Program, local health authorities, a hospital and the federal university.
Pfizer said the purpose was to study the behaviour of COVID-19 in a "real life scenario" after the population has been vaccinated.
"The initiative is the first and only of its kind to be undertaken in a developing country in collaboration with the pharmaceutical company," it added.
Iran denies talks with US after Trump postpones strikes on power grid
Kim Jong Un says North Korea’s nuclear status is irreversible, threatens South
At least 34 killed in Colombia military plane crash, governor says
Ukraine's Zelenskyy says Russia preparing new massive attack
Rockets launched from Iraq’s Mosul towards US base in Syria
